- Home
- HOUR vs RNXT Comparison
HOUR vs RNXT Comparison
Compare HOUR & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- RNXT
- Stock Information
- Founded
- HOUR 2015
- RNXT 2012
- Country
- HOUR United States
- RNXT United States
- Employees
- HOUR N/A
- RNXT N/A
- Industry
- HOUR Catalog/Specialty Distribution
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- HOUR Consumer Discretionary
- RNXT Health Care
- Exchange
- HOUR Nasdaq
- RNXT Nasdaq
- Market Cap
- HOUR 43.2M
- RNXT 44.6M
- IPO Year
- HOUR 2022
- RNXT 2021
- Fundamental
- Price
- HOUR $1.29
- RNXT $1.41
- Analyst Decision
- HOUR
- RNXT Strong Buy
- Analyst Count
- HOUR 0
- RNXT 2
- Target Price
- HOUR N/A
- RNXT $7.00
- AVG Volume (30 Days)
- HOUR 24.8K
- RNXT 235.1K
- Earning Date
- HOUR 06-13-2025
- RNXT 05-15-2025
- Dividend Yield
- HOUR N/A
- RNXT N/A
- EPS Growth
- HOUR N/A
- RNXT N/A
- EPS
- HOUR 0.01
- RNXT N/A
- Revenue
- HOUR $139,408,829.00
- RNXT $240,000.00
- Revenue This Year
- HOUR N/A
- RNXT $3,927.91
- Revenue Next Year
- HOUR N/A
- RNXT $219.75
- P/E Ratio
- HOUR $186.13
- RNXT N/A
- Revenue Growth
- HOUR 2.71
- RNXT N/A
- 52 Week Low
- HOUR $0.83
- RNXT $0.75
- 52 Week High
- HOUR $6.90
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- HOUR 46.39
- RNXT 67.63
- Support Level
- HOUR $1.22
- RNXT $1.34
- Resistance Level
- HOUR $1.34
- RNXT $1.45
- Average True Range (ATR)
- HOUR 0.08
- RNXT 0.08
- MACD
- HOUR 0.00
- RNXT 0.01
- Stochastic Oscillator
- HOUR 26.43
- RNXT 75.36
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.